Flonidan
Ask a doctor about a prescription for Flonidan
How to use Flonidan
Package Leaflet: Information for the Patient
Flonidan, 10 mg, Tablets
Loratadine
Read the package leaflet carefully before taking the medicine, as it contains important information for the patient.
- Keep this leaflet, you may need to read it again.
- If you have any further questions, ask your doctor or pharmacist.
- This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours.
- If you experience any side effects, including those not listed in this leaflet, tell your doctor or pharmacist. See section 4.
Table of Contents of the Leaflet
- 1. What is Flonidan and what is it used for
- 2. Important information before taking Flonidan
- 3. How to take Flonidan
- 4. Possible side effects
- 5. How to store Flonidan
- 6. Contents of the pack and other information
1. What is Flonidan and what is it used for
Loratadine, the active substance of Flonidan, belongs to a group of antihistamine medicines. During an allergic reaction, various substances (so-called mediators) are released, causing the development of allergy symptoms. One of the most important mediators is histamine. Flonidan inhibits the activity of histamine, thus showing anti-allergic action. The medicine relieves the following symptoms caused by histamine during an allergic reaction: itching, redness, swelling, and nasal discharge. Flonidan relieves symptoms associated with: allergic rhinitis, such as sneezing, runny nose, or nasal itching, itching of the palate, redness or tearing of the eyes; chronic urticaria of unknown cause (i.e., chronic idiopathic urticaria), such as blisters on the skin, swelling, and itching.
2. Important information before taking Flonidan
When not to take Flonidan:
if you are allergic to loratadine or any of the other ingredients of this medicine (listed in section 6).
Warnings and precautions
Discuss with your doctor or pharmacist if: the medicine is taken for a long time; after taking Flonidan, allergy symptoms do not subside or worsen; you have severe liver function disorders. Flonidan should be discontinued at least 2 days before skin allergy tests, as it may mask symptoms of hypersensitivity and inhibit or weaken a positive reaction to allergens detected by these tests. After the test, the medicine can be taken as before.
Children
The medicine should not be taken by children under 2 years of age or by children with a body weight of less than 30 kg.
Flonidan and other medicines
Tell your doctor about all medicines you are taking or have recently taken, as well as medicines you plan to take. This is especially important for medicines such as: cimetidine (a medicine used to reduce stomach acid production); ketoconazole or fluconazole (medicines used to treat fungal infections); erythromycin (an antibiotic); fluoxetine (a medicine used to treat certain mental disorders).
Flonidan with food, drink, and alcohol
The medicine can be taken regardless of meals. The tablet should be swallowed whole, without chewing, with a liquid. Flonidan does not enhance the effect of alcohol, but it is not recommended to drink alcohol while taking this medicine.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a child, consult your doctor or pharmacist before taking this medicine. Although loratadine has not been shown to be harmful to the fetus or newborn, as a precaution, Flonidan should be avoided in pregnant women. Loratadine passes into breast milk, so it is not recommended to take Flonidan during breastfeeding.
Driving and using machines
Studies have shown that the medicine, when taken in recommended doses, does not affect or has a negligible effect on the ability to drive or operate machines. However, very rarely, taking the medicine may cause drowsiness, which can impair the ability to perform these activities.
Flonidan contains lactose
One tablet contains 71.3 mg of lactose monohydrate. If you have previously been diagnosed with intolerance to some sugars, you should consult your doctor before taking the medicine. One tablet of Flonidan contains less than 0.01 IU.
3. How to take Flonidan
This medicine should always be taken exactly as advised by your doctor. Do not change the dose or stop taking the medicine without consulting your doctor first. If you are unsure, consult your doctor or pharmacist. Adults and children over 12 years:1 tablet (10 mg) once a day. Children from 2 to 12 years(with a body weight over 30 kg): 1 tablet (10 mg) once a day. In children with a body weight of less than 30 kg, the use of 10 mg tablets is not recommended. In children from 2 to 12 years, it is recommended to use Flonidan in the form of an oral suspension. Flonidan should not be given to children under 2 years of age.
Patients with liver function disorders
Adults and children with a body weight over 30 kg: 1 tablet of Flonidan (10 mg) every other day. Method of administration: see "Flonidan with food, drink, and alcohol" in section 2. If you feel that the effect of Flonidan is too strong or too weak, consult your doctor or pharmacist.
Taking more than the recommended dose of Flonidan
If you have taken too many tablets, contact your doctor immediately. Overdose may cause drowsiness, headache, and rapid heartbeat. The medicine should be removed from the gastrointestinal tract as soon as possible. Treatment of overdose is symptomatic.
Missing a dose of Flonidan
If you forget to take the medicine at the usual time, take it as soon as you remember. If it is almost time for the next dose, do not take the missed tablet, but return to the usual dosing schedule. Do not take a double dose to make up for the missed dose. If you have any further questions about taking this medicine, consult your doctor or pharmacist.
4. Possible side effects
Like all medicines, Flonidan can cause side effects, although not everybody gets them. Common side effects(may affect up to 1 in 10 people): headache, nervousness, drowsiness, feeling of fatigue (in children); drowsiness (in adults and adolescents). Uncommon side effects(may affect up to 1 in 100 people): headache, increased appetite, and sleep disorders (in adults and adolescents). Rare side effects(may affect up to 1 in 10,000 people): hypersensitivity reactions(including angioedema - swelling of the skin and/or mucous membranes, e.g., in the face, limbs, joints), severe allergic reactionswith sudden breathing difficulties, severe dizziness, or fainting, swelling of the face or throat (anaphylaxis). If you experience any of these symptoms, seek medical attention immediately. rapid heartbeat, palpitations, gastritis, nausea, liver function disorders, dry mouth, dizziness, feeling of fatigue, rash, hair loss, seizures. Side effects with unknown frequency(frequency cannot be estimated from available data): weight gain.
Reporting side effects
If you experience any side effects, including those not listed in this leaflet, tell your doctor, pharmacist, or nurse. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products: Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: +48 22 49 21 301, fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl. Side effects can also be reported to the marketing authorization holder. By reporting side effects, you can help provide more information on the safety of this medicine.
5. How to store Flonidan
Keep the medicine out of the sight and reach of children. Do not use this medicine after the expiry date stated on the packaging after EXP. The expiry date refers to the last day of the month. Store below 25°C. Protect from light and moisture. Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
6. Contents of the pack and other information
What Flonidan contains
- The active substance of Flonidan is loratadine. Each tablet contains 10 mg of loratadine.
- The other ingredients are: corn starch, lactose monohydrate, magnesium stearate, pregelatinized starch.
What Flonidan looks like and contents of the pack
Flonidan tablets are white or almost white, round, with a dividing line on one side, making them easier to break. The tablets can be divided into halves. The medicine is packaged in PVC/Aluminum blisters in a cardboard box. The packs contain 10, 30, 60, or 90 tablets.
Marketing authorization holder
Sandoz GmbH, Biochemiestrasse 10, A-6250 Kundl, Austria
Manufacturer
Lek Pharmaceuticals d.d., Verovškova 57, 1526 Ljubljana, Slovenia, Lek Pharmaceuticals d.d., Trimlini 2d, 9220 Lendava, Slovenia. For more information, contact: Sandoz Polska Sp. z o.o., ul. Domaniewska 50 C, 02-672 Warsaw, tel. 22 209 70 00. Logo Sandoz. Date of last revision of the leaflet:10/2024
- Country of registration
- Active substance
- Prescription requiredYes
- ImporterLek Pharmaceuticals d.d. Lek Pharmaceuticals d.d.
- This information is for reference only and does not constitute medical advice. Always consult a licensed doctor before taking any medication. Oladoctor is not responsible for medical decisions based on this content.
- Alternatives to FlonidanDosage form: Tablets, 10 mgActive substance: loratadineManufacturer: US Pharmacia Sp. z o.o.Prescription requiredDosage form: Tablets, 5 mg + 120 mgActive substance: loratadineManufacturer: SAG MANUFACTURING, S.L.U.Prescription not requiredDosage form: Tablets, 10 mgActive substance: loratadineManufacturer: Bayer Bitterfeld GmbHPrescription not required
Alternatives to Flonidan in other countries
The best alternatives with the same active ingredient and therapeutic effect.
Alternative to Flonidan in Spain
Alternative to Flonidan in Ukraine
Online doctors for Flonidan
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for Flonidan – subject to medical assessment and local rules.
Get updates and exclusive offers
Be the first to know about new services, marketplace updates, and subscriber-only promos.
